331 related articles for article (PubMed ID: 20926642)
1. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
Bokemeyer M; Ding XQ; Goldbecker A; Raab P; Heeren M; Arvanitis D; Tillmann HL; Lanfermann H; Weissenborn K
Gut; 2011 Mar; 60(3):370-7. PubMed ID: 20926642
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
3. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
Byrnes V; Miller A; Lowry D; Hill E; Weinstein C; Alsop D; Lenkinski R; Afdhal NH
J Hepatol; 2012 Mar; 56(3):549-56. PubMed ID: 22027578
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.
Forton DM; Thomas HC; Murphy CA; Allsop JM; Foster GR; Main J; Wesnes KA; Taylor-Robinson SD
Hepatology; 2002 Feb; 35(2):433-9. PubMed ID: 11826420
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
6. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
8. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
9. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
10. In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes.
McLean MA; Woermann FG; Simister RJ; Barker GJ; Duncan JS
Neuroimage; 2001 Aug; 14(2):501-9. PubMed ID: 11467922
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
[TBL] [Abstract][Full Text] [Related]
12. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
15. Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.
Mechtcheriakov S; Schocke M; Kugener A; Graziadei IW; Mattedi M; Hinterhuber H; Vogel W; Marksteiner J
Neuroradiology; 2005 Jan; 47(1):27-34. PubMed ID: 15655660
[TBL] [Abstract][Full Text] [Related]
16. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
[TBL] [Abstract][Full Text] [Related]
17. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
19. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
20. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]